 | • レポートコード：GIR-107A12324 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、蠕虫感染症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。蠕虫感染症治療の種類別市場規模（ベンズイミダゾール、ピランテル、クエン酸ピペラジン、その他）、用途別市場規模（蟯虫、無鉤条虫、回虫、鞭虫、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・蠕虫感染症治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Neural Analytics, Inc.、M3 Biotechnology, Inc.、Cerevance、Mitochon Pharmaceuticals, Inc.、Peptilogics、Farmoquimica S/A、biOasis Technologies, Inc.、HCA Healthcare, Inc.、Alzeca Biosciences, Inc.、Johnson & Johnson ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ベンズイミダゾール、ピランテル、クエン酸ピペラジン、その他 ・用途別分析2016年-2026年：蟯虫、無鉤条虫、回虫、鞭虫、その他 ・蠕虫感染症治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・蠕虫感染症治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・蠕虫感染症治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・蠕虫感染症治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・蠕虫感染症治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Helminthic Infestations Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Helminthic Infestations Therapeutics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Helminthic Infestations Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Helminthic Infestations Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Benzimidazole
Pyrantel
Piperazine Citrate
Others
Market segment by Application, can be divided into
Enterobius vermicularis
Taenia saginata
Ascaris lumbricoides
Trichuris trichiura
Others
Market segment by players, this report covers
Neural Analytics, Inc.
M3 Biotechnology, Inc.
Cerevance
Mitochon Pharmaceuticals, Inc.
Peptilogics
Farmoquimica S/A
biOasis Technologies, Inc.
HCA Healthcare, Inc.
Alzeca Biosciences, Inc.
Johnson & Johnson
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Helminthic Infestations Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Helminthic Infestations Therapeutics, with revenue, gross margin and global market share of Helminthic Infestations Therapeutics from 2019 to 2021.
Chapter 3, the Helminthic Infestations Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Helminthic Infestations Therapeutics market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Helminthic Infestations Therapeutics research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Helminthic Infestations Therapeutics
1.2 Classification of Helminthic Infestations Therapeutics by Type
1.2.1 Overview: Global Helminthic Infestations Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Helminthic Infestations Therapeutics Revenue Market Share by Type in 2020
1.2.3 Benzimidazole
1.2.4 Pyrantel
1.2.5 Piperazine Citrate
1.2.6 Others
1.3 Global Helminthic Infestations Therapeutics Market by Application
1.3.1 Overview: Global Helminthic Infestations Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Enterobius vermicularis
1.3.3 Taenia saginata
1.3.4 Ascaris lumbricoides
1.3.5 Trichuris trichiura
1.3.6 Others
1.4 Global Helminthic Infestations Therapeutics Market Size & Forecast
1.5 Global Helminthic Infestations Therapeutics Market Size and Forecast by Region
1.5.1 Global Helminthic Infestations Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Helminthic Infestations Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Helminthic Infestations Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Helminthic Infestations Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Helminthic Infestations Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Helminthic Infestations Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Helminthic Infestations Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Helminthic Infestations Therapeutics Market Drivers
1.6.2 Helminthic Infestations Therapeutics Market Restraints
1.6.3 Helminthic Infestations Therapeutics Trends Analysis
2 Company Profiles
2.1 Neural Analytics, Inc.
2.1.1 Neural Analytics, Inc. Details
2.1.2 Neural Analytics, Inc. Major Business
2.1.3 Neural Analytics, Inc. Helminthic Infestations Therapeutics Product and Solutions
2.1.4 Neural Analytics, Inc. Helminthic Infestations Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Neural Analytics, Inc. Recent Developments and Future Plans
2.2 M3 Biotechnology, Inc.
2.2.1 M3 Biotechnology, Inc. Details
2.2.2 M3 Biotechnology, Inc. Major Business
2.2.3 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Product and Solutions
2.2.4 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 M3 Biotechnology, Inc. Recent Developments and Future Plans
2.3 Cerevance
2.3.1 Cerevance Details
2.3.2 Cerevance Major Business
2.3.3 Cerevance Helminthic Infestations Therapeutics Product and Solutions
2.3.4 Cerevance Helminthic Infestations Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Cerevance Recent Developments and Future Plans
2.4 Mitochon Pharmaceuticals, Inc.
2.4.1 Mitochon Pharmaceuticals, Inc. Details
2.4.2 Mitochon Pharmaceuticals, Inc. Major Business
2.4.3 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Product and Solutions
2.4.4 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Mitochon Pharmaceuticals, Inc. Recent Developments and Future Plans
2.5 Peptilogics
2.5.1 Peptilogics Details
2.5.2 Peptilogics Major Business
2.5.3 Peptilogics Helminthic Infestations Therapeutics Product and Solutions
2.5.4 Peptilogics Helminthic Infestations Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Peptilogics Recent Developments and Future Plans
2.6 Farmoquimica S/A
2.6.1 Farmoquimica S/A Details
2.6.2 Farmoquimica S/A Major Business
2.6.3 Farmoquimica S/A Helminthic Infestations Therapeutics Product and Solutions
2.6.4 Farmoquimica S/A Helminthic Infestations Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Farmoquimica S/A Recent Developments and Future Plans
2.7 biOasis Technologies, Inc.
2.7.1 biOasis Technologies, Inc. Details
2.7.2 biOasis Technologies, Inc. Major Business
2.7.3 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Product and Solutions
2.7.4 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 biOasis Technologies, Inc. Recent Developments and Future Plans
2.8 HCA Healthcare, Inc.
2.8.1 HCA Healthcare, Inc. Details
2.8.2 HCA Healthcare, Inc. Major Business
2.8.3 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Product and Solutions
2.8.4 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 HCA Healthcare, Inc. Recent Developments and Future Plans
2.9 Alzeca Biosciences, Inc.
2.9.1 Alzeca Biosciences, Inc. Details
2.9.2 Alzeca Biosciences, Inc. Major Business
2.9.3 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Product and Solutions
2.9.4 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Alzeca Biosciences, Inc. Recent Developments and Future Plans
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson Helminthic Infestations Therapeutics Product and Solutions
2.10.4 Johnson & Johnson Helminthic Infestations Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Johnson & Johnson Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Helminthic Infestations Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Helminthic Infestations Therapeutics Players Market Share
3.2.2 Top 10 Helminthic Infestations Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Helminthic Infestations Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Helminthic Infestations Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Helminthic Infestations Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Helminthic Infestations Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Helminthic Infestations Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Helminthic Infestations Therapeutics Revenue by Type (2016-2026)
6.2 North America Helminthic Infestations Therapeutics Revenue by Application (2016-2026)
6.3 North America Helminthic Infestations Therapeutics Market Size by Country
6.3.1 North America Helminthic Infestations Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Helminthic Infestations Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Helminthic Infestations Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Helminthic Infestations Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Helminthic Infestations Therapeutics Revenue by Type (2016-2026)
7.2 Europe Helminthic Infestations Therapeutics Revenue by Application (2016-2026)
7.3 Europe Helminthic Infestations Therapeutics Market Size by Country
7.3.1 Europe Helminthic Infestations Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Helminthic Infestations Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Helminthic Infestations Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Helminthic Infestations Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Helminthic Infestations Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Helminthic Infestations Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Helminthic Infestations Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Helminthic Infestations Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Region
8.3.1 Asia-Pacific Helminthic Infestations Therapeutics Revenue by Region (2016-2026)
8.3.2 China Helminthic Infestations Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Helminthic Infestations Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Helminthic Infestations Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Helminthic Infestations Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Helminthic Infestations Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Helminthic Infestations Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Helminthic Infestations Therapeutics Revenue by Type (2016-2026)
9.2 South America Helminthic Infestations Therapeutics Revenue by Application (2016-2026)
9.3 South America Helminthic Infestations Therapeutics Market Size by Country
9.3.1 South America Helminthic Infestations Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Helminthic Infestations Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Helminthic Infestations Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Helminthic Infestations Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Helminthic Infestations Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Country
10.3.1 Middle East & Africa Helminthic Infestations Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Helminthic Infestations Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Helminthic Infestations Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Helminthic Infestations Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Helminthic Infestations Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Helminthic Infestations Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Helminthic Infestations Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Helminthic Infestations Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Helminthic Infestations Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Neural Analytics, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Neural Analytics, Inc. Major Business
Table 8. Neural Analytics, Inc. Helminthic Infestations Therapeutics Product and Solutions
Table 9. Neural Analytics, Inc. Helminthic Infestations Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. M3 Biotechnology, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. M3 Biotechnology, Inc. Major Business
Table 12. M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Product and Solutions
Table 13. M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Cerevance Corporate Information, Head Office, and Major Competitors
Table 15. Cerevance Major Business
Table 16. Cerevance Helminthic Infestations Therapeutics Product and Solutions
Table 17. Cerevance Helminthic Infestations Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Mitochon Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Mitochon Pharmaceuticals, Inc. Major Business
Table 20. Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Product and Solutions
Table 21. Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Peptilogics Corporate Information, Head Office, and Major Competitors
Table 23. Peptilogics Major Business
Table 24. Peptilogics Helminthic Infestations Therapeutics Product and Solutions
Table 25. Peptilogics Helminthic Infestations Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Farmoquimica S/A Corporate Information, Head Office, and Major Competitors
Table 27. Farmoquimica S/A Major Business
Table 28. Farmoquimica S/A Helminthic Infestations Therapeutics Product and Solutions
Table 29. Farmoquimica S/A Helminthic Infestations Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. biOasis Technologies, Inc. Corporate Information, Head Office, and Major Competitors
Table 31. biOasis Technologies, Inc. Major Business
Table 32. biOasis Technologies, Inc. Helminthic Infestations Therapeutics Product and Solutions
Table 33. biOasis Technologies, Inc. Helminthic Infestations Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. HCA Healthcare, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. HCA Healthcare, Inc. Major Business
Table 36. HCA Healthcare, Inc. Helminthic Infestations Therapeutics Product and Solutions
Table 37. HCA Healthcare, Inc. Helminthic Infestations Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Alzeca Biosciences, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Alzeca Biosciences, Inc. Major Business
Table 40. Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Product and Solutions
Table 41. Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 43. Johnson & Johnson Major Business
Table 44. Johnson & Johnson Helminthic Infestations Therapeutics Product and Solutions
Table 45. Johnson & Johnson Helminthic Infestations Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Helminthic Infestations Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 47. Global Helminthic Infestations Therapeutics Revenue Share by Players (2019-2021)
Table 48. Breakdown of Helminthic Infestations Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Helminthic Infestations Therapeutics Players Head Office, Products and Services Provided
Table 50. Helminthic Infestations Therapeutics Mergers & Acquisitions in the Past Five Years
Table 51. Helminthic Infestations Therapeutics New Entrants and Expansion Plans
Table 52. Global Helminthic Infestations Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 53. Global Helminthic Infestations Therapeutics Revenue Share by Type (2016-2021)
Table 54. Global Helminthic Infestations Therapeutics Revenue Forecast by Type (2021-2026)
Table 55. Global Helminthic Infestations Therapeutics Revenue by Application (2016-2021)
Table 56. Global Helminthic Infestations Therapeutics Revenue Forecast by Application (2021-2026)
Table 57. North America Helminthic Infestations Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Helminthic Infestations Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Helminthic Infestations Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Helminthic Infestations Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Helminthic Infestations Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Helminthic Infestations Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Helminthic Infestations Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Helminthic Infestations Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Helminthic Infestations Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Helminthic Infestations Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Helminthic Infestations Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Helminthic Infestations Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Helminthic Infestations Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Helminthic Infestations Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Helminthic Infestations Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Helminthic Infestations Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Helminthic Infestations Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Helminthic Infestations Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Helminthic Infestations Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Helminthic Infestations Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Helminthic Infestations Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Helminthic Infestations Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Helminthic Infestations Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Helminthic Infestations Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Helminthic Infestations Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Helminthic Infestations Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Helminthic Infestations Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Helminthic Infestations Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Helminthic Infestations Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Helminthic Infestations Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Helminthic Infestations Therapeutics Picture
Figure 2. Global Helminthic Infestations Therapeutics Revenue Market Share by Type in 2020
Figure 3. Benzimidazole
Figure 4. Pyrantel
Figure 5. Piperazine Citrate
Figure 6. Others
Figure 7. Helminthic Infestations Therapeutics Revenue Market Share by Application in 2020
Figure 8. Enterobius vermicularis Picture
Figure 9. Taenia saginata Picture
Figure 10. Ascaris lumbricoides Picture
Figure 11. Trichuris trichiura Picture
Figure 12. Others Picture
Figure 13. Global Helminthic Infestations Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Helminthic Infestations Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Helminthic Infestations Therapeutics Revenue Market Share by Region (2016-2026)
Figure 16. Global Helminthic Infestations Therapeutics Revenue Market Share by Region in 2020
Figure 17. North America Helminthic Infestations Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Helminthic Infestations Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Helminthic Infestations Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Helminthic Infestations Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa Helminthic Infestations Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Helminthic Infestations Therapeutics Market Drivers
Figure 23. Helminthic Infestations Therapeutics Market Restraints
Figure 24. Helminthic Infestations Therapeutics Market Trends
Figure 25. Neural Analytics, Inc. Recent Developments and Future Plans
Figure 26. M3 Biotechnology, Inc. Recent Developments and Future Plans
Figure 27. Cerevance Recent Developments and Future Plans
Figure 28. Mitochon Pharmaceuticals, Inc. Recent Developments and Future Plans
Figure 29. Peptilogics Recent Developments and Future Plans
Figure 30. Farmoquimica S/A Recent Developments and Future Plans
Figure 31. biOasis Technologies, Inc. Recent Developments and Future Plans
Figure 32. HCA Healthcare, Inc. Recent Developments and Future Plans
Figure 33. Alzeca Biosciences, Inc. Recent Developments and Future Plans
Figure 34. Johnson & Johnson Recent Developments and Future Plans
Figure 35. Global Helminthic Infestations Therapeutics Revenue Share by Players in 2020
Figure 36. Helminthic Infestations Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players Helminthic Infestations Therapeutics Revenue Market Share in 2020
Figure 38. Global Top 10 Players Helminthic Infestations Therapeutics Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global Helminthic Infestations Therapeutics Revenue Share by Type in 2020
Figure 41. Global Helminthic Infestations Therapeutics Market Share Forecast by Type (2021-2026)
Figure 42. Global Helminthic Infestations Therapeutics Revenue Share by Application in 2020
Figure 43. Global Helminthic Infestations Therapeutics Market Share Forecast by Application (2021-2026)
Figure 44. North America Helminthic Infestations Therapeutics Sales Market Share by Type (2016-2026)
Figure 45. North America Helminthic Infestations Therapeutics Sales Market Share by Application (2016-2026)
Figure 46. North America Helminthic Infestations Therapeutics Revenue Market Share by Country (2016-2026)
Figure 47. United States Helminthic Infestations Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Helminthic Infestations Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Helminthic Infestations Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Helminthic Infestations Therapeutics Sales Market Share by Type (2016-2026)
Figure 51. Europe Helminthic Infestations Therapeutics Sales Market Share by Application (2016-2026)
Figure 52. Europe Helminthic Infestations Therapeutics Revenue Market Share by Country (2016-2026)
Figure 53. Germany Helminthic Infestations Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Helminthic Infestations Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Helminthic Infestations Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Helminthic Infestations Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Helminthic Infestations Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Helminthic Infestations Therapeutics Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific Helminthic Infestations Therapeutics Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Helminthic Infestations Therapeutics Revenue Market Share by Region (2016-2026)
Figure 61. China Helminthic Infestations Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Helminthic Infestations Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea Helminthic Infestations Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Helminthic Infestations Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Helminthic Infestations Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Helminthic Infestations Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Helminthic Infestations Therapeutics Sales Market Share by Type (2016-2026)
Figure 68. South America Helminthic Infestations Therapeutics Sales Market Share by Application (2016-2026)
Figure 69. South America Helminthic Infestations Therapeutics Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Helminthic Infestations Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Helminthic Infestations Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa Helminthic Infestations Therapeutics Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa Helminthic Infestations Therapeutics Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa Helminthic Infestations Therapeutics Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Helminthic Infestations Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Helminthic Infestations Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE Helminthic Infestations Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
蠕虫感染症治療法市場：世界及び中国市場分析・予測（～2024年） Helminthic Infestations Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Helminthic Infestations Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of …- 世界の糖鎖生物学（診断・治療）市場 2021：企業別、地域別、種類・用途別 The Glycobiology (Diagnostics and Therapeutics) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 世界の特発性血小板減少性紫斑病（ITP）治療市場 2021：企業別、地域別、種類・用途別 The Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value ch…
- 世界の性感染症治療市場 2021：企業別、地域別、種類・用途別 The Sexually Transmitted Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 世界の未熟児網膜症治療市場 2021：企業別、地域別、種類・用途別 The Retinopathy Of Prematurity Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…